Gene therapy represents one of the most significant advances in modern medicine. It also represents one of the most complex commercial challenges the pharmaceutical industry has ever faced. Traditional pharmaceutical launches are built around physician adoption, recurring prescriptions, and expanding market share over time. Gene therapy follows a very different model. Success depends on identifying a small number of appropriate patients, preparing highly specialized treatment centers, coordinating complex logistics, and…
Full article
Full article available by request only.
Contact PharmaKonsult to request the complete opinion paper.